# EDGAR Filing Document

**Accession Number:** 0001843575
**File Stem:** 0001493152-23-005012
**Filing Date:** 2023-2
**Character Count:** 6487
**Document Hash:** 56acc8efe6b0faff3bd26958c5eed23d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-23-005012.hdr.sgml**: 20230214

**ACCESSION NUMBER**: 0001493152-23-005012

**CONFORMED SUBMISSION TYPE**: SC 13G/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230214

**DATE AS OF CHANGE**: 20230214

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Landos Biopharma, Inc.
- **CENTRAL INDEX KEY:** 0001785345
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 815085535
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-92247
- **FILM NUMBER:** 23631157

**BUSINESS ADDRESS:**
- **STREET 1:** 1800 KRAFT DRIVE, SUITE 216
- **CITY:** BLACKSBURG
- **STATE:** VA
- **ZIP:** 24060
- **BUSINESS PHONE:** 540-818-2844

**MAIL ADDRESS:**
- **STREET 1:** 1800 KRAFT DRIVE, SUITE 216
- **CITY:** BLACKSBURG
- **STATE:** VA
- **ZIP:** 24060
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Bassaganya-Riera Josep
- **CENTRAL INDEX KEY:** 0001843575

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A

**MAIL ADDRESS:**
- **STREET 1:** 1800 KRAFT DRIVE
- **STREET 2:** SUITE 100
- **CITY:** BLACKSBURG
- **STATE:** VA
- **ZIP:** 24060

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Riera Josep Bassaganya
- **DATE OF NAME CHANGE:** 20210201

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**SCHEDULE 13G/A** 

**Under the Securities Exchange Act of 1934**

**(Amendment No. 1)\*** 

**Landos Biopharma, Inc.**

(Name of Issuer)

Common Stock

(Title of Class of Securities)

515069102

(CUSIP Number)

December 31, 2022

(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☐ Rule 13d-1(c)

☒ Rule 13d-1(d)

<sup>\*</sup> The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 515069102 13G Page 2 of 5 Pages

1. NAMES
 OF REPORTING PERSONS I.R.S.
 IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Josep
 Bassaganya-Riera

2. CHECK
 THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see
 instructions) (a)
 ☐ (b)
 ☐

3. SEC
 USE ONLY

4. CITIZENSHIP
 OR PLACE OF ORGANIZATION USA

---

| | | |
|:---|:---|:---|
| NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON WITH | 5. | SOLE VOTING POWER<br>5,720,868 (1)<br>|
| NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON WITH | 6. | SHARED VOTING POWER<br>0 |
| NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON WITH | 7. | SOLE DISPOSITIVE POWER<br>5,720,868 (1) |
| NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON WITH | 8. | SHARED DISPOSITIVE POWER<br>0 |

---

9. AGGREGATE
 AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 5,720,868
 (1)

10. CHECK
 IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see
 instructions) ☐

11. PERCENT
 OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 14.2%

12. TYPE
 OF REPORTING PERSON (see instructions) IN

&nbsp;&nbsp;&nbsp;&nbsp;(1) Consists
 of shares held by trusts under which Mr. Bassaganya-Riera is the sole trustee and the beneficiaries
 are Mr. Bassaganya-Riera and/or his immediate family members. Mr. Bassaganya-Riera disclaims
 beneficial ownership of these securities, except to the extent of his pecuniary interest
 therein.

CUSIP No. 515069102 13G Page 3 of 5 Pages

**Item 1.**

---

| | |
|:---|:---|
| (a) | Name of Issuer |
|  | Landos Biopharma, Inc. |
| (b) | Address of Issuer's Principal Executive Offices |
|  | P.O. Box 11239, Blacksburg VA 24062 |

---

**Item 2.**

---

| | |
|:---|:---|
| (a) | Name of Person Filing |
|  | Josep Bassaganya-Riera |
| (b) | Address of the Principal Office or, if none, residence |
|  | c/o BioTherapeutics, Inc, 1800 Kraft Drive, Suite 100, Blacksburg VA 24060 |
| (c) | Citizenship |
|  | USA |
| (d) | Title of Class of Securities |
|  | Common Stock |
| (e) | CUSIP Number |
|  | 515069102 |

---

**Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:**

N/A

**Item 4. Ownership.**

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

(a) Amount
 beneficially owned: 5,720,868 (1)

(b) Percent
 of class: 14.2%

(c) Number
 of shares as to which the person has:

(i) Sole
 power to vote or to direct the vote 5,720,868 (1)

(ii) Shared
 power to vote or to direct the vote 0

(iii) Sole
 power to dispose or to direct the disposition of 5,720,868 (1)

(iv) Shared
 power to dispose or to direct the disposition of 0

&nbsp;&nbsp;&nbsp;&nbsp;(1) Consists
 of shares held by trusts under which Mr. Bassaganya-Riera is the sole trustee and the beneficiaries
 are Mr. Bassaganya-Riera and/or his immediate family members. Mr. Bassaganya-Riera disclaims
 beneficial ownership of these securities, except to the extent of his pecuniary interest
 therein.

CUSIP No. 515069102 13G Page 4 of 5 Pages

**Item 5. Ownership of Five Percent or Less of a Class.**

N/A

**Item 6. Ownership of More than Five Percent on Behalf of Another Person.**

N/A

**Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.**

N/A

**Item 8. Identification and Classification of Members of the Group.**

N/A

**Item 9. Notice of Dissolution of Group.**

N/A

**Item 10. Certification.**

N/A

CUSIP No. 515069102 13G Page 5 of 5 Pages

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

---

| |
|:---|
| 02/14/2023  |
| Date |
| /s/ *Josep Bassaganya-Riera* |
| Signature |
| Josep Bassaganya-Riera |
| Name/Title |

---